Yap1 inhibitors that target the interaction of yap1 with oct4
AssigneeH.Lee Moffitt Cancer and Research Institute, Inc.
InventorsSrikumar CHELLAPAN, Nicholas J. LAWRENCE, Sujeewa Ranatunga Mahanthe MUDIYANSELAGE
Life of this patent
Estimating the term…